Your browser doesn't support javascript.
loading
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
Lok, Anna S; Perrillo, Robert; Lalama, Christina M; Fried, Michael W; Belle, Steven H; Ghany, Marc G; Khalili, Mandana; Fontana, Robert J; Sterling, Richard K; Terrault, Norah; Feld, Jordan J; Di Bisceglie, Adrian M; Lau, Daryl T Y; Hassan, Mohamed; Janssen, Harry L A.
Afiliación
  • Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
  • Perrillo R; Hepatology Division, Baylor Scott and White Medical Center, Dallas, TX.
  • Lalama CM; Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
  • Fried MW; UNC Liver Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Belle SH; Epidemiology and Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
  • Ghany MG; Liver Diseases Branch, NIDDK, NIH, Bethesda, MD.
  • Khalili M; Department of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, CA.
  • Fontana RJ; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
  • Sterling RK; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA.
  • Terrault N; Division of Gastrointestinal and Liver Diseases, Keck Medicine of University of Southern California, Los Angeles, CA.
  • Feld JJ; Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Di Bisceglie AM; Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO.
  • Lau DTY; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Hassan M; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolois, MN.
  • Janssen HLA; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada.
Hepatology ; 73(6): 2124-2140, 2021 06.
Article en En | MEDLINE | ID: mdl-32936969
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Hepatitis B Crónica / Alanina Transaminasa / Antígenos e de la Hepatitis B / Cirrosis Hepática / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Hepatology Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Hepatitis B Crónica / Alanina Transaminasa / Antígenos e de la Hepatitis B / Cirrosis Hepática / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Hepatology Año: 2021 Tipo del documento: Article